CV Sciences, Inc.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology… (via Wikipedia)
Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-07 | 2026-09-09 | CHEEVER CHARLIE E III | 10% Owner | Purchase | 94.9K | $0.02 | $2K | 26.65M | View | |
| 2026-08-04 | 2026-09-09 | CHEEVER CHARLIE E III | 10% Owner | Purchase | 108.0K | $0.02 | $2K | 26.55M | View | |
| 2026-07-31 | 2026-09-09 | CHEEVER CHARLIE E III | 10% Owner | Purchase | 1.73M | $0.02 | $35K | 26.45M | View | |
| 2026-07-29 | 2026-09-09 | CHEEVER CHARLIE E III | 10% Owner | Purchase | 60.0K | $0.02 | $1K | 24.72M | View | |
| 2026-07-28 | 2026-09-09 | CHEEVER CHARLIE E III | 10% Owner | Purchase | 1.83M | $0.02 | $37K | 24.66M | View |
Informational purposes only, not investment advice.
tormere.com/research/CVSI · generated 2026-10-28
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology…
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-07 | CHEEVER CHARLIE E III | P | 94,854 | $1,897.08 |
| 2026-08-04 | CHEEVER CHARLIE E III | P | 108,000 | $2,160 |
| 2026-07-31 | CHEEVER CHARLIE E III | P | 1,730,000 | $34,600 |
| 2026-07-29 | CHEEVER CHARLIE E III | P | 60,000 | $1,200 |
| 2026-07-28 | CHEEVER CHARLIE E III | P | 1,830,000 | $36,600 |
Tormere — informational purposes only, not investment advice.